Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07XXT
|
|||
| Former ID |
DNCL002343
|
|||
| Drug Name |
DEDN-6526A
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Company |
Genentech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01522664) A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.